The Effect of Giving Salak (Salacca Zalacca) Bark Extract on Liver Function and Histopathological Features of the Liver of Male Wistar White Rats Obesity Model
Keywords:
Salak Bark Extract, Liver, NAFLD, ObisityAbstract
Nonalcoholic fatty liver disease (NAFLD) Lifestyle factors contribute to fatty liver disease. Physical activity, weight loss, and antioxidant-rich components like Salak herb are used to minimize liver disease. The study examined how Salak bark extract affected liver function in white male Wistar rats, an obesity model, and histopathology. An actual experiment or laboratory experimental design is used in this quantitative research. Four experimental groups of 24 mice were employed. Research data was analyzed with SPSS 25.0. Normality test findings reveal 2-tailed significance of 0.991 > 0.05. The One-Way ANOVA test at a 95% confidence level for the SGOT liver function analysis data showed the same variance, 0.233 (p>0.05) and 0.718 (p>0.05) for the SGPT liver function analysis. Histopathological studies showed snake fruit extract at 300mg/BW scored 3 (Hydropic degeneration), 500mg/BW scored 2 (Parenchymatous degeneration), and 700mg/BW scored 1 (Normal). The phytochemical screening of alkaloids, flavonoids, saponins, tannins, and glycosides demonstrated that Salak bark extract's secondary metabolite concentration contains antioxidant-effective active components. The study demonstrated no inflammation, cell improvement, necrosis, or fat at 700 mg/BW.
Downloads
References
M. Cernikova, D. Smahel, and M. F. Wright, “Children’s Experiences and Awareness about Impact of Digital Media on Health,” Health Commun., vol. 33, no. 6, pp. 664–673, 2018, doi: 10.1080/10410236.2017.1298197.
U. Ansari and F. Naz, “Impact of Digital Media Communication on Children Health: Analyses Using Open Data Barometer’ in Education System,” Pjer, vol. 4, no. 1, pp. 416–437, 2021.
C. Khutami, S. A. Sumiwi, N. K. Khairul Ikram, and M. Muchtaridi, “The Effects of Antioxidants from Natural Products on Obesity, Dyslipidemia, Diabetes and Their Molecular Signaling Mechanism,” Int. J. Mol. Sci., vol. 23, no. 4, p. 2056, Feb. 2022, doi: 10.3390/ijms23042056.
World Health Organization, “Obesity and overweight,” World Health Organization. Accessed: Oct. 21, 2023. [Online]. Available: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
W. Kiess et al., “Clinical aspects of obesity in childhood and adolescence,” Obes. Rev., vol. 2, no. 1, pp. 29–36, 2001, doi: 10.1046/j.1467-789x.2001.00017.x.
H. Morinaga et al., “Obesity Accelerates Hair Thinning By Stem Cell-centric Converging Mechanism,” Nature, vol. 595, no. 7866, pp. 266–271, 2021, doi: 10.1038/s41586-021-03624-x.Obesity.
S. A. Polyzos, J. Kountouras, and C. S. Mantzoros, “Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics,” Metabolism., vol. 92, no. xxxx, pp. 82–97, 2019, doi: 10.1016/j.metabol.2018.11.014.
W. Elger, W. Kiess, A. Körner, A. Schrock, M. Vogel, and C. Hirsch, “Influence of overweight/obesity, socioeconomic status, and oral hygiene on caries in primary dentition,” J. Investig. Clin. Dent., vol. 10, no. 2, p. e12394, 2019, doi: 10.1111/jicd.12394.
B. A. Neuschwander-Tetri, “Non-alcoholic fatty liver disease,” BMC Med., vol. 15, no. 1, pp. 1–6, 2017, doi: 10.1186/s12916-017-0806-8.
E. E. Powell, V. W. S. Wong, and M. Rinella, “Non-alcoholic fatty liver disease,” Lancet, vol. 397, no. 10290, pp. 2212–2224, 2021, doi: 10.1016/S0140-6736(20)32511-3.
S. K. Asrani, H. Devarbhavi, J. Eaton, and P. S. Kamath, “Burden of liver diseases in the world,” J. Hepatol., vol. 70, no. 1, pp. 151–171, 2019, doi: 10.1016/j.jhep.2018.09.014.
E. L. Anderson et al., “Childhood energy intake is associated with nonalcoholic fatty liver disease in adolescents,” J. Nutr., vol. 145, no. 5, pp. 983–989, 2015, doi: 10.3945/jn.114.208397.
A. B. Engin and A. Engin, Obesity and Lipotoxicity, vol. 960. Ankara, Turkey: Springer International Publishing, 2017. doi: 10.1007/978-3-319-48382-5.
S. Mitra, A. De, and A. Chowdhury, “Epidemiology of non-alcoholic and alcoholic fatty liver diseases,” Transl. Gastroenterol. Hepatol., vol. 5, pp. 1–17, 2020, doi: 10.21037/TGH.2019.09.08.
S. Bellentani, “The epidemiology of non-alcoholic fatty liver disease,” Liver Int., vol. 37, no. October 2016, pp. 81–84, 2017, doi: 10.1111/liv.13299.
P. Bedossa, “Pathology of non-alcoholic fatty liver disease,” Liver Int., vol. 37, no. October 2016, pp. 85–89, 2017, doi: 10.1111/liv.13301.
S. M. Francque et al., “Non-alcoholic fatty liver disease: A patient guideline,” JHEP Reports, vol. 3, no. 5, p. 100322, 2021, doi: 10.1016/j.jhepr.2021.100322.
J. C. Ozougwu, “Physiology of the liver,” Int. J. Res. Pharm. Biosci., vol. 14, no. 8, pp. 13–24, 2017, doi: 10.1016/0002-9343(54)90342-3.
N. Méndez-Sánchez et al., “Current trends of liver cirrhosis in Mexico: Similitudes and differences with other world regions,” World J. Clin. Cases, vol. 6, no. 15, pp. 922–930, 2018, doi: 10.12998/wjcc.v6.i15.922.
D. A. Koutoukidis et al., “The effect of the magnitude of weight loss on non-alcoholic fatty liver disease: a systematic review and meta-analysis,” Metabolism, vol. 115, no. February, p. 154455, 2021, doi: 10.1016/j.metabol.2020.154455.
S. M. Francque et al., “Non-alcoholic fatty liver disease: A patient guideline,” JHEP Reports, vol. 3, no. 5, 2021, doi: 10.1016/j.jhepr.2021.100322.
L. C. Bertot and L. A. Adams, “The natural course of non-alcoholic fatty liver disease,” Int. J. Mol. Sci., vol. 17, no. 5, 2016, doi: 10.3390/ijms17050774.
M. L. Petroni, L. Brodosi, E. Bugianesi, and G. Marchesini, “Management of non-alcoholic fatty li V er di S ease”.
K. Hallsworth and L. A. Adams, “Lifestyle modification in NAFLD/NASH: Facts and figures,” JHEP Reports, vol. 1, no. 6, pp. 468–479, 2019, doi: 10.1016/j.jhepr.2019.10.008.
E. Vilar-Gomez et al., “Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis,” Gastroenterology, vol. 149, no. 2, pp. 367-378.e5, 2015, doi: 10.1053/j.gastro.2015.04.005.
M. S. M. Saleh et al., “Salacca zalacca: A short review of the palm botany, pharmacological uses and phytochemistry,” Asian Pac. J. Trop. Med., vol. 11, no. 12, pp. 645–652, 2018, doi: 10.4103/1995-7645.248321.
Y. Pujiawati, L. Khotijah, and I. K. G. Wiryawan, “Screening of antioxidant activities and their bioavailability of tropical plants,” IOP Conf. Ser. Earth Environ. Sci., vol. 1182, no. 1, 2023, doi: 10.1088/1755-1315/1182/1/012083.
S. Notoatmodjo, Metodologi Penelitian Kesehatan, 3rd ed. Jakarta: Rineka Cipta, 2022.
B. Suwarno and A. Nugroho, Kumpulan Variabel-Variabel Penelitian Manajemen Pemasaran (Definisi & Artikel Publikasi), 1st ed. Bogor: Halaman Moeka Publishing, 2023.
I. Ghozali, Aplikasi Analisis Multivariate dengan Program IBM SPSS 25. Semarang, 2018.
A. Mazzotti, M. Turchese, C. A. S. Sasdelli, L. Brodosi, and G. Marchesini, “Pathophysiology of Nonalcoholic Fatty Liver Disease: Lifestyle-Gut-Gene Interaction,” Dig. Dis., vol. 34, no. 1, pp. 3–10, 2016, doi: 10.1159/000447275.
Published
How to Cite
Issue
Section
Copyright (c) 2024 Ade Arhami, Lina Tantoso Djohan, Horas Rajagukguk
This work is licensed under a Creative Commons Attribution 4.0 International License.
